22 June 2022 - The Tufts Cost-Effectiveness Analysis Registry was used to identify all CEAs published in Medline between 1976 and ...
17 June 2022 - Givlaari (givosiran) is included in the high-cost protection with limited subsidy to reduce attacks in patients with ...
17 June 2022 - Speaking about the waiver, EFPIA Director General, Nathalie Moll said. “The decision is a serious retrograde step ...
16 June 2022 - On Wednesday PHARMAC announced $190 million to fund cancer treatments and other medicines. ...
20 June 2022 - The decision to waive intellectual property protections for COVID-19 vaccines is fundamentally flawed and will have ...
17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...
17 June 2022 - Last-ditch effort by Democrats to pass slimmed-down version of Build Back Better could include measures on drug ...
17 June 2022 - The aim of this study was to find ways of bridging the gap in opinions concerning health ...
14 June 2022 - Two prominent Democratic lawmakers are requesting that the Federal Trade Commission investigate whether price hikes for ...
16 June 2022 - Hugel said Thursday that it has obtained product approval from Health Canada for its botulinum toxin ...
15 June 2022 - New drug price regulations set to come into effect next month could lower spending on patented ...
17 June 2022 - EMA has started a rolling review for a version of Spikevax adapted to provide better protection ...
17 June 2022 - mRNA-1273 has been administered to millions of children and adolescents over the age of 6 worldwide, ...
17 June 2022 - In a Phase 2/3 clinical trial, the Pfizer-BioNTech COVID-19 vaccine elicited a strong immune response in this ...
17 June 2022 - Submission seeks approval of momelotinib for the treatment of myelofibrosis. ...
16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...